
Home » Pfizer Says Off-Label Marketing FCA Suit Falls Short
Pfizer Says Off-Label Marketing FCA Suit Falls Short
Pfizer asked a Massachusetts federal court to dismiss a False Claims Act whistleblower suit alleging that it improperly promoted off-label use of a schizophrenia drug, saying that the plaintiffs have failed to show that the drugmaker actually defrauded federal health care programs.
Law360
Law360
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct